Barclays ''The worst of the global pandemic now seems to be behind us.'' Covid-19 Vaccine24 Sep 2020 13:52
Published 24th September 2020
Betting On A Vaccine.
Barclays says the economy is back strongly led by the U.S.
and it “prefers global equities over fixed income” as a “vaccine approval is likely by year end.” "The worst of the global pandemic now seems to be behind us. Economies across the world have continued to re-open, COVID mortality rates have been dropping in many regions for months", a Barclays research note says.
Also UBS suggests betting on a vaccine as expectations of quick medical progress were “reinforced today as another major U.S. healthcare company, Johnson & Johnson, announced that it has begun Phase 3 clinical trials.”
Johnson & Johnson said it expects to take until year-end or Q1 to be able to get an endpoint to show efficacy of Covid-19 vaccine.
“We remain constructive that the US will pass an additional fiscal package, although it is less likely to happen before the election,” a UBS research note says.
The Swiss bank sees choppy markets and suggests taking advantage of the volatility.